The Anti Radiation Drugs market is estimated to be valued at US$ 587.4 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Anti radiation drugs are used to protect healthy cells from getting damaged by radiation during radiation therapy for cancer treatment. These drugs protect normal cells from damage caused by radiation ... Read more

The anti radiation drugs market comprises pharmaceutical products that are used to prevent or treat the harmful effects of ionizing radiation exposure on normal body tissues. Anti radiation drugs aid in reducing the impact of radiation exposure from diagnostic and therapeutic medical procedures such as computed tomography scans and cancer radiotherapy treatments. They help protect healthy cells from radiation-induced damage during cancer treatment and allows higher radiation doses to be used ... Read more

Anti radiation drugs are prescribed medications used to protect the body from harmful effects of radiation exposure. These drugs assist in protecting radiation sensitive tissues and organs like bone marrow, gastrointestinal tract etc. from DNA damage caused by ionizing radiation. With increasing usage of electronic devices like computers, cell phones and other wireless devices which emit low level radiation, the risk of associated health issues has also risen. This has boosted the demand for ... Read more